Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements (French, HTML)
Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements: French HTML file. From Health Canada, updated Jul 2021. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2021-07-29
COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file